Amrize falls as 2025 guidance misses expectations

Amrize AG

07/08/2025 08:48

** Shares in Amrize AMRZ.S fall 8.4% to the bottom of Switzerland's blue-chip index .SSMI after its published 2025 guidance below investors expectations alongside its H1 results

** Amrize said it expected to reach revenue of $11-4-$11.8 billion and adjusted EBITDA of $2.9-$3.1 billion in 2025

** "The introduced FY25 outlook both on sales and adj. EBITDA is well below market expectations and will weigh on shares," Vontobel writes

** However, the broker notes that the launched cost savings program should more than offset the standalone costs from 2026 onwards

** Amrize's stock is on track for its worst day ever since it started trading on the Swiss stock exchange in June

 (Reporting by Tristan Veyet)

 ((tristan.chabba@thomsonreuters.com))